Daniel Edmonston (@danedmonston) 's Twitter Profile
Daniel Edmonston

@danedmonston

@dukekidney faculty | @DCRINews faculty | Tweets do not constitute medical advice or represent any organization.

ID: 3292698654

calendar_today25-07-2015 13:37:22

946 Tweet

609 Followers

288 Following

ASN Kidney News (@kidneynews) 's Twitter Profile Photo

Editor's Choice: Cardio-nephrology Services around the United States: Experience of Three Centers of Excellence In this article, leaders from US centers’ cardiorenal services provide insights into the creation of their services & the benefits they provide bit.ly/41l6qNH

Editor's Choice: Cardio-nephrology Services around the United States: Experience of Three Centers of Excellence

In this article, leaders from US centers’ cardiorenal services provide insights into the creation of their services & the benefits they provide bit.ly/41l6qNH
Daniel Edmonston (@danedmonston) 's Twitter Profile Photo

Still lots to learn about cardiorenal implications of the decline in Klotho with CKD. Thanks to the CRIC Study for supporting this work and AJKD for publishing and providing great constructive feedback.

Daniel Edmonston (@danedmonston) 's Twitter Profile Photo

Happy FLOW day to those who celebrate! Truly a showcase of the kidney-cardiovascular-metabolic connection. We've reached 4 GDMTs with cardiorenal benefit for select patients with CKD. Time to implement... #era24 ERA - European Renal Association NEJM

Daniel Edmonston (@danedmonston) 's Twitter Profile Photo

Excited to share our recently published work in AJKD on the association between Klotho levels and clinical outcomes in CKD supported by the CRIC Study! 🚨Free access via this link until 7/28/24. authors.elsevier.com/a/1jE1Vz-QWLWBv Duke Kidney

Excited to share our recently published work in <a href="/AJKDonline/">AJKD</a> on the association between Klotho levels and clinical outcomes in CKD supported by the <a href="/CRICStudy/">CRIC Study</a>! 
🚨Free access via this link until 7/28/24. authors.elsevier.com/a/1jE1Vz-QWLWBv
<a href="/DukeKidney/">Duke Kidney</a>
Daniel Edmonston (@danedmonston) 's Twitter Profile Photo

Excited to share our Duke Clinical Research Institute study comparing kidney and CV outcomes between empagliflozin and DPP4i initiators across 20 US healthcare systems contributing to #PCORnet published in American Journal of Cardiology! Early separation in kidney composite outcome. Duke Kidney ajconline.org/article/S0002-…

Excited to share our <a href="/DCRINews/">Duke Clinical Research Institute</a> study comparing kidney and CV outcomes between empagliflozin and DPP4i initiators across 20 US healthcare systems contributing to #PCORnet published in <a href="/AmJCardio/">American Journal of Cardiology</a>! Early separation in kidney composite outcome. <a href="/DukeKidney/">Duke Kidney</a> 
ajconline.org/article/S0002-…
Daniel Edmonston (@danedmonston) 's Twitter Profile Photo

How well are we screening for and treating CKD in T2D? 🚨Excited to announce that our Duke Clinical Research Institute work evaluating concordance with CKD screening and treatment guidelines in T2D is now available on JAMA Network Open! jamanetwork.com/journals/jaman…

How well are we screening for and treating CKD in T2D? 🚨Excited to announce that our <a href="/DCRINews/">Duke Clinical Research Institute</a> work evaluating concordance with CKD screening and treatment guidelines in T2D is now available on <a href="/JAMANetworkOpen/">JAMA Network Open</a>! 
jamanetwork.com/journals/jaman…
Duke Clinical Research Institute (@dcrinews) 's Twitter Profile Photo

The new IRIS-CKD study, which features DCRI's Neha Pagidipati as the study lead, looks to address the issue of many T2DM patients lacking access to proper information and care to determine the status of their kidney health. Learn more via the link in the post below 👇

Opeyemi Olabisi (@opeyemiolabisi8) 's Twitter Profile Photo

🚨 We're hiring! The Olabisi Lab at Duke University seeks a Mouse Technician skilled in drug administration, sample collection, and colony management. Contribute to impactful kidney disease research in Durham, NC. 100% in-person. Apply now: Link 🔬🐁 #ResearchJobs #DukeUniversity

Daniel Edmonston (@danedmonston) 's Twitter Profile Photo

I'm excited to share our publication in JACC Journals from our excellent Duke Clinical Research Institute team that compares the kidney and CV effectiveness of SGLT2i vs GLP-1RA in people with T2D! Great editorial from Brendon Neuen & scottdavidsolomon. Free access until 10/1/24: authors.elsevier.com/a/1jaqg2d9GH%7…

I'm excited to share our publication in <a href="/JACCJournals/">JACC Journals</a> from our excellent <a href="/DCRINews/">Duke Clinical Research Institute</a> team that compares the kidney and CV effectiveness of SGLT2i vs GLP-1RA in people with T2D! Great editorial from <a href="/brendonneuen/">Brendon Neuen</a> &amp; <a href="/scottdsolomon/">scottdavidsolomon</a>.  Free access until 10/1/24: authors.elsevier.com/a/1jaqg2d9GH%7…
CardioHealthAlliance (@alliancecardio) 's Twitter Profile Photo

CardioHealthAlliance Study Lead Dr. Neha Pagidipati discusses 2 Alliance studies, Test 2 Treat, and IRIS-CKD, which aim to enhance treatment for patients with #ASCVD and #CKD. Watch: youtube.com/watch?v=foEggu…

JACC Journals (@jaccjournals) 's Twitter Profile Photo

🌟 Original Research in #JACC: Comparison of SGLT2 inhibitors & GLP1RAs in T2D shows similar kidney & CV outcomes, but SGLT2 inhibitors offer superior eGFR slope & ⬇️ risk of 40% eGFR decline. 📃 Explore the full article here: bit.ly/3AtAqhR #Diabetes @danedmonston

🌟 Original Research in #JACC: Comparison of SGLT2 inhibitors &amp; GLP1RAs in T2D shows similar kidney &amp; CV outcomes, but SGLT2 inhibitors offer superior eGFR slope &amp; ⬇️ risk of 40% eGFR decline.

📃 Explore the full article here: bit.ly/3AtAqhR #Diabetes @danedmonston
Duke Clinical Research Institute (@dcrinews) 's Twitter Profile Photo

Today at #AHA24, DCRI Fellow Benjamin Cantanese discussed the impact of GLP-1RAs on cardiac outcomes for patients with end-stage renal disease.

Today at #AHA24, DCRI Fellow Benjamin Cantanese discussed the impact of GLP-1RAs on cardiac outcomes for patients with end-stage renal disease.
CardioHealthAlliance (@alliancecardio) 's Twitter Profile Photo

If the kidneys don’t work well, the heart is not going to work well. Javed Butler discusses CardioHealthAlliance IRIS-CKD study and why improving screening + management for CKD in patients with diabetes can lead to improved heart health. 🎥Watch: youtube.com/watch?v=T5Bgj4…